Sign In
Buy STRO
$23.57
-0.160 (-0.674%)
At Close: Jul 17, 2026
Sutro (STRO) Ovarian Cancer Drug Gets FDA's Fast Track Tag
10:45am, Thursday, 19'th Aug 2021
Sutro's (STRO) investigational antibody-drug conjugate therapy, STRO-002, gets Fast Track designation from the FDA for advanced ovarian cancer.
Sutro Biopharma's Ovarian Cancer Candidate Fast Tracked In US
08:05am, Wednesday, 18'th Aug 2021
The FDA has granted Fast Track designation to Sutro Biopharma Inc's (NASDAQ: STRO) STRO-002 for ovarian cancer. The designation covers platinum-resistant epithelial ovarian, fallopian tube, or pri
Sutro Biopharma Announces STRO-002 FDA Fast Track Designation for Patients with Advanced Ovarian Cancer
07:00am, Wednesday, 18'th Aug 2021
SOUTH SAN FRANCISCO, Calif., Aug. 18, 2021 /PRNewswire/ -- Sutro Biopharma, Inc. (NASDAQ: STRO), a clinical-stage drug discovery, development and manufacturing company focused on the application of p
Sutro Biopharma, Inc. (STRO) Reports Q2 Loss, Tops Revenue Estimates
10:04am, Monday, 09'th Aug 2021
Sutro Biopharma, Inc. (STRO) delivered earnings and revenue surprises of 69.05% and 103.25%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Sutro Biopharma Reports Second Quarter 2021 Financial Results, Business Highlights and Anticipated Second Half 2021 Milestones
07:05am, Monday, 09'th Aug 2021
SOUTH SAN FRANCISCO, Calif., Aug. 9, 2021 /PRNewswire/ -- Sutro Biopharma, Inc. (NASDAQ: STRO), a clinical-stage drug discovery, development and manufacturing company focused on the application of pr
Sutro Biopharma Appoints Jane Chung as Chief Commercial Officer
07:00am, Monday, 09'th Aug 2021
SOUTH SAN FRANCISCO, Calif., Aug. 9, 2021 /PRNewswire/ -- Sutro Biopharma, Inc. (NASDAQ: STRO), a clinical-stage drug discovery, development and manufacturing company focused on the application of pr
Sutro Biopharma to Participate in the 12th Annual Wedbush PacGrow Healthcare Virtual Conference
07:00am, Thursday, 29'th Jul 2021
SOUTH SAN FRANCISCO, Calif., July 29, 2021 /PRNewswire/ -- Sutro Biopharma, Inc. (NASDAQ: STRO), a clinical-stage drug discovery, development and manufacturing company focused on the application of p
Sutro Biopharma, Inc. (STRO) Surges 6.4%: Is This an Indication of Further Gains?
05:17pm, Monday, 21'st Jun 2021
Sutro Biopharma, Inc. (STRO) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the
Sutro Biopharma to Participate in Two Virtual Investor Conferences in June
07:09am, Tuesday, 15'th Jun 2021
SOUTH SAN FRANCISCO, Calif., June 15, 2021 /PRNewswire/ -- Sutro Biopharma, Inc. (NASDAQ: STRO), a clinical-stage drug discovery, development and manufacturing company focused on the application of p
Sutro Biopharma Receives Undisclosed Milestone Payment Under Bispecific ADC Collaboration with Merck
02:02pm, Tuesday, 01'st Jun 2021
Sutro Biopharma Inc (NASDAQ: STRO) has received a milestone payment under its collaboration and license agreement with the healthcare division of Merck KGaA Germany (OTC: MKGAF). The payment is r
Sutro Biopharma Earns Milestone Payment from Bispecific Antibody-Drug Conjugate Collaboration with Merck KGaA, Darmstadt, Germany
07:00am, Tuesday, 01'st Jun 2021
SOUTH SAN FRANCISCO, Calif., June 1, 2021 /PRNewswire/ -- Sutro Biopharma, Inc. (NASDAQ: STRO), clinical-stage drug discovery, development and manufacturing company focused on the application of preci
Sutro Biopharma Announces Additional Data for Dose-Escalation Phase 1 Study of STRO-002 to be Presented at ASCO 2021
05:00pm, Wednesday, 19'th May 2021
SOUTH SAN FRANCISCO, Calif., May 19, 2021 /PRNewswire/ -- Sutro Biopharma, Inc. (NASDAQ: STRO), a clinical-stage drug discovery, development and manufacturing company focused on the application of pr
Sutro Biopharma to Participate in Upcoming Virtual Investor Conferences
07:00am, Friday, 14'th May 2021
SOUTH SAN FRANCISCO, Calif., May 14, 2021 /PRNewswire/ -- Sutro Biopharma, Inc. (NASDAQ: STRO), a clinical-stage drug discovery, development and manufacturing company focused on the application of pr
Sutro Biopharma Reports First Quarter 2021 Financial Results, Business Highlights and 2021 Anticipated Milestones
07:00am, Friday, 07'th May 2021
SOUTH SAN FRANCISCO, Calif., May 7, 2021 /PRNewswire/ -- Sutro Biopharma, Inc. (NASDAQ: STRO), a clinical-stage drug discovery, development and manufacturing company focused on the application of pre
Sutro Biopharma Earns Milestone Payment from Cytokine Derivatives Collaboration with Merck
07:00am, Thursday, 15'th Apr 2021
SOUTH SAN FRANCISCO, Calif., April 15, 2021 /PRNewswire/ -- Sutro Biopharma, Inc. (NASDAQ: STRO), a clinical-stage drug discovery, development and manufacturing company focused on the application of
